Data Foundry

Drug recalls 2021

Daytrana — Class II drug recall D-0296-2021

Terminated recall by Noven Pharmaceuticals Inc, reported 2021-03-10, distributed nationwide. Defective Delivery System: Out of specification for mechanical peel.

Recall numberD-0296-2021
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmNoven Pharmaceuticals Inc, Miami, FL, United States
Recall initiated2021-02-19
Classified2021-03-03
Reported by FDA2021-03-10
Terminated2024-07-05
DistributedNationwide (US)
Quantity934,140 patches
Reason classesspecification failure
NDC68968-5552, 68968-5552-03, 68968-5553, 68968-5553-03, 68968-5554, 68968-5554-03, 68968-5555, 68968-5555-03
Lot numbers87377, 87572, 87581, 87820, 88246, 88535, 88536, 88537, 88939
Expiration dates2021-03, 2021-04, 2021-05, 2021-06, 2021-07, 2021-08

Product

Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5555-3.

Reason for recall

Defective Delivery System: Out of specification for mechanical peel.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0296-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.